APA (7th ed.) Citation

Zhang, M., Huang, J., Zheng, X., Huang, P., & Yang, X. Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma. Nature Portfolio.

Chicago Style (17th ed.) Citation

Zhang, Miaomiao, Jinlong Huang, Xiaochun Zheng, Ping Huang, and Xiuli Yang. Cost-effectiveness Analysis of Eribulin Versus Dacarbazine in Patients with Advanced Liposarcoma. Nature Portfolio.

MLA (9th ed.) Citation

Zhang, Miaomiao, et al. Cost-effectiveness Analysis of Eribulin Versus Dacarbazine in Patients with Advanced Liposarcoma. Nature Portfolio.